Edition:
United States

Dr.Reddy's Laboratories Ltd (REDY.BO)

REDY.BO on Bombay Stock Exchange

2,161.20INR
4:59am EST
Change (% chg)

Rs9.35 (+0.43%)
Prev Close
Rs2,151.85
Open
Rs2,156.00
Day's High
Rs2,186.40
Day's Low
Rs2,145.00
Volume
21,405
Avg. Vol
53,495
52-wk High
Rs2,948.00
52-wk Low
Rs1,901.65

Latest Key Developments (Source: Significant Developments)

Dr.Reddy's Laboratories Says Amended Complaint w.r.t U.S. Class Action Lawsuit Filed
Monday, 19 Feb 2018 01:33am EST 

Feb 19 (Reuters) - Dr.Reddy's Laboratories Ltd ::W.R.T U.S. CLASS ACTION LAWSUIT, AMENDED COMPLAINT FILED BY PLAINTIFF WHERE CHAIRMAN, COO AND U.S. UNIT ADDED AS DEFENDANTS.  Full Article

Dr.Reddy's Lab Announces Launch Of Tetrabenazine Tablets In U.S. Market
Friday, 2 Feb 2018 12:59am EST 

Feb 2 (Reuters) - Dr.Reddy's Laboratories Ltd ::SAYS ANNOUNCEMENT OF LAUNCH OF TETRABENAZINE TABLETS IN U.S. MARKET.  Full Article

India's Dr.Reddy's Laboratories Dec-Qtr Consol Net PAT Falls 38.5 Pct
Thursday, 25 Jan 2018 01:31am EST 

Jan 25 (Reuters) - Dr.Reddy's Laboratories Ltd ::DEC QUARTER CONSOL NET PROFIT AFTER TAX 3.03 BILLION RUPEES VERSUS PROFIT OF 4.92 BILLION RUPEES LAST YEAR.DEC QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 38.34 BILLION RUPEES VERSUS 37.23 BILLION RUPEES LAST YEAR.CONSENSUS FORECAST FOR DEC QUARTER CONSOL PROFIT WAS 3.40 BILLION RUPEES.  Full Article

Dr.Reddy's Laboratories Updates on Re-inspection At Formulations Mfg Plant In Bachupally
Wednesday, 24 Jan 2018 08:21am EST 

Jan 24 (Reuters) - Dr.Reddy's Laboratories Ltd ::THERE HAS BEEN RE-INSPECTION BY GERMAN REGULATOR AT CO'S FORMULATIONS MANUFACTURING UNIT 2 PLANT IN BACHUPALLY, HYDERABAD‍​.BETAPHARM INFORMED THAT CURRENT STATUS OF EU GMP NON-COMPLIANCE IS TO BE WITHDRAWN FROM GOVERNMENT. OF UPPER BAVARIA.  Full Article

Dr.Reddy's Laboratories Launches Melphalan Hydrochloride Injection In U.S.
Tuesday, 26 Dec 2017 03:50am EST 

Dec 26 (Reuters) - Dr.Reddy's Laboratories Ltd ::SAYS LAUNCH OF MELPHALAN HYDROCHLORIDE FOR INJECTION IN U.S. MARKET.  Full Article

Dr.Reddy's Labs Disagrees' With U.S. Govt. Allegations On Drug Packaging Not Tested For Child Safety
Monday, 18 Dec 2017 10:13pm EST 

Dec 19 (Reuters) - Dr.Reddy's Laboratories Ltd ::DR.REDDY'S LABORATORIES 'FIRMLY DISAGREES' WITH U.S. GOVERNMENT ALLEGATIONS THAT CO SOLD PRESCRIPTION DRUGS IN U.S. IN PACKAGING NOT TESTED FOR CHILD SAFETY.NOT AWARE OF REPORTS THAT PRODUCTS CAUSED CHILDREN HARM AS A RESULT OF PACKAGING.  Full Article

Dr.Reddy's Labs Gets EIR From U.S. FDA ‍​For Facility In Hyderabad
Friday, 1 Dec 2017 05:29am EST 

Dec 1 (Reuters) - Dr.Reddy's Laboratories Ltd ::SAYS GETS EIR FROM U.S. FDA ‍​FOR CUSTOM PHARMA SERVICES FACILITY IN HYDERABAD.  Full Article

Dr.Reddy's Labs Gets U.S. FDA Nod For Psoriasis Treatment
Thursday, 30 Nov 2017 11:33pm EST 

Dec 1 (Reuters) - Dr.Reddy's Laboratories Ltd ::SAYS CO, THROUGH UNIT, GETS NDA NOD FOR PSORIASIS TREATMENT.  Full Article

Dr.Reddy's Laboratories gets German Regulator's Nod For CAPA Plan
Thursday, 30 Nov 2017 03:19am EST 

Nov 30 (Reuters) - Dr.Reddy's Laboratories Ltd ::SAYS GERMANY REGULATOR APPROVES CO'S CAPA PLAN.SAYS GERMAN REGULATOR PERMITTED PRODUCTION TO START AGAIN FROM FACILITY FOR EU MARKET‍​.SAYS GERMANY REGULATOR TO RE-INSPECT DUVVADA FACILITY BY END-2018.  Full Article

Dr.Reddy's Laboratories gets EIR from US FDA for Duvvada facility
Monday, 20 Nov 2017 11:54pm EST 

Nov 21 (Reuters) - Dr.Reddy's Laboratories Ltd ::Says got EIR from US FDA for formulations manufacturing facility at Duvvada, Vishakhapatnam‍​.Says FDA has explained that the inspection has not closed and site's status remains unchanged.Planning to request a re-inspection in 2018.  Full Article

BRIEF-Dr.Reddy's Laboratories Says Amended Complaint w.r.t U.S. Class Action Lawsuit Filed

* W.R.T U.S. CLASS ACTION LAWSUIT, AMENDED COMPLAINT FILED BY PLAINTIFF WHERE CHAIRMAN, COO AND U.S. UNIT ADDED AS DEFENDANTS Source text - http://bit.ly/2CvdcnN Further company coverage: